RECURRENT BLADDER CARCINOMA
Clinical trials for RECURRENT BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets genetic weakness in bladder cancer
Disease control OngoingThis phase 2 trial tests a drug called sapanisertib in 17 people with advanced bladder cancer that has a specific genetic change (TSC1 or TSC2 mutation). The drug works by blocking a protein that helps cancer cells grow. Researchers want to see if the drug can shrink tumors and h…
Matched conditions: RECURRENT BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Gene-Guided cancer therapy: a new hope for advanced tumors?
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced or hard-to-treat cancers had their tumors genetically tested. Those with specific genetic changes received drugs designed to targe…
Matched conditions: RECURRENT BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:49 UTC